πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7105169

Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7105643

Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the sa

The United States of America as represented by the Attorney General of the Dept. of Justice Β· Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7105488

G protein-coupled receptor antagonists

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7105170

Latent human tuberculosis model, diagnostic antigens, and methods of use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7101541

Utilization of non-viral sequences for minus-strand DNA transfer and gene reconstitution

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7101548

Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathol

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7101547

Method for the prevention and treatment of diseases caused by an inflammatory response med

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7097965

Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion prot

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7094045

Microencapsulation system and method

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration Β· Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7094883

Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7094598

Development of a preventive vaccine for filovirus infection in primates

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7094411

Avirulent, immunogenic flavivirus chimeras

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7094408

Immunogenicity using a combination of DNA and vaccinia virus vector vaccines

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7094406

Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes ther

The United States of America as represented by the Secretary of the Department of Health and Human Services and Genelabs Technologies, Inc. Β· Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7094405

Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7094404

Method for treating malignancy and autoimmune disorders in humans using tac antibodies

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7090852

Venezuelan equine encephalitis virus replicon encoding marburg virus proteins

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 15 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7087589

Methanocarba cycloakyl nucleoside analogues

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7087591

21-substituted progesterone derivatives as new antiprogestational agents

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7087234

Recombinant multivalent viral vaccine

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7084239

Cancer peptides of NY-ESO-1/CAG-3

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7084266

Cloned genome of infectious hepatitus C virus of genotype 2A and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7084132

Artemisinins with improved stability and bioavailability for therapeutic drug development

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7081518

Anti-mesothelin antibodies having high binding affinity

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted